CME SymposiA

Navigating the Evolving Treatment Landscape in Fibrosing ILD: A Multidisciplinary Case-Based Approach

Sheraton Phoenix Downtown, Phoenix Ballroom D&E
CME Provider: National Jewish Health. This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

---

Program Description

Fibrosing interstitial lung disease (ILD) presents complex challenges in recognizing progression, selecting appropriate treatment, and coordinating multidisciplinary care. In this interactive CME breakfast symposium, experts in pulmonology, rheumatology, and radiology will use practical, case-based discussion to examine evolving approaches to the assessment and management of fibrosing ILD.

Using high-resolution computed tomography (HRCT) findings and multidisciplinary perspectives, faculty will explore how to recognize progressive pulmonary fibrosis, identify clinical factors that may warrant treatment initiation or reassessment, integrate immunomodulatory and antifibrotic approaches when appropriate, and evaluate new and emerging evidence in the context of individualized patient care. Attendees will gain practical strategies for navigating complex treatment decisions and improving longitudinal management of patients with fibrosing ILD.

1.0 CME/MOC

Register at NJHealth.org/ILDTreatment

This symposium is not supported, endorsed, or accredited by CHEST, unless otherwise noted.

Panelists

Melissa Griffith, MD, RhMSUS
University of Colorado School of Medicine
Division of Rheumatology
Associate Professor of Medicine
Aurora, CO

David A. Lynch, MB, BCh
National Jewish Health
Department of Radiology
Professor of Radiology
Denver, CO

Joshua J. Solomon, MD
National Jewish Health
Critical Care Medicine
Professor of Medicine

Center for Interstitial Lung Disease
Director
Denver, CO